Loading
What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/alcor.md — the filesystem corpus, unchanged. Not an edit.
12.8 kB
Revision 1
Revision 2
lines 7–13 → 7–136 unchanged lines not shown
categories: ["organizations", "longevity"]categories: ["organizations", "longevity"]tags: ["cryonics", "cryopreservation", "nonprofit", "death", "trusts", "vitrification"]tags: ["cryonics", "cryopreservation", "nonprofit", "death", "trusts", "vitrification"]summary: "A United States cryonics organization, founded in 1972, that preserves legally dead members at cryogenic temperatures under a trust structure meant to fund storage indefinitely."summary: "A United States cryonics organization, founded in 1972, that preserves legally dead members at cryogenic temperatures under a trust structure meant to fund storage indefinitely."updated: "2026-07-27"updated: "2026-10-29"issues: ["Patient and member counts are given as approximations with no source.", "The 1979 collapse of a Californian cryonics competitor is described without a source."]issues: ["Patient and member counts are given as approximations with no source.", "The 1979 collapse of a Californian cryonics competitor is described without a source."]------ lines 26–32 → 26–3212 unchanged lines not shown
}}`````` **Alcor Life Extension Foundation** is a nonprofit organization in Scottsdale, Arizona that performs and maintains human [[cryonics|cryopreservation]]. Founded in California in 1972, it is among the largest such organizations by number of patients in storage and has done more than most to formalize the practice — standby teams, vitrification protocols, and a segregated trust intended to fund liquid nitrogen indefinitely. It makes no claim that revival is currently possible, and its own literature describes the arrangement as a bet.**Alcor Life Extension Foundation** is a nonprofit organization in Scottsdale, Arizona that performs and maintains human [[cryonics|cryopreservation]]. Founded in California in 1972, it is among the largest such organizations by number of patients in storage, and it has done more than most to formalize the practice with standby teams, vitrification protocols and a segregated trust intended to fund liquid nitrogen indefinitely. It makes no claim that revival is currently possible, and its own literature describes the arrangement as a bet. ```keyfacts```keyfacts[[lines 38–105 → 38–1055 unchanged lines not shown
## Overview## Overview Alcor's function is administrative as much as technical. Preservation must begin immediately after a physician pronounces death, which requires knowing when a member is dying, having people and equipment in place, and having a legal instrument that survives family objection. The organization's procedures are built around that timing problem, and its documented failures have generally been failures of logistics rather than of cryobiology.Alcor's work is administrative as much as technical. Preservation must begin immediately after a physician pronounces death, which requires knowing when a member is dying, having people and equipment in place, and holding a legal instrument that survives family objection. The organization's procedures are built around that timing problem, and its documented failures have generally been failures of logistics rather than of cryobiology. The rule cuts the other way as well: nothing may be done before pronouncement, which guarantees an interval of warm ischemia and rules out preserving a member whose brain is being destroyed by a progressive disease while they remain legally alive. That constraint sits awkwardly beside [[right-to-die-and-right-to-live|assisted-dying law]] and has been challenged unsuccessfully in court.The same rule cuts the other way. Nothing may be done before pronouncement, which guarantees an interval of warm ischemia and rules out preserving a member whose brain is being destroyed by a progressive disease while they remain legally alive. That constraint sits awkwardly beside [[right-to-die-and-right-to-live|assisted-dying law]] and has been challenged unsuccessfully in court. Members sign a contract and fund it, most commonly by naming Alcor as beneficiary of a life insurance policy, which converts a large capital cost into a manageable premium and makes the arrangement cheap for the already insurable — one narrow instance of the [[access-and-inequality]] problem that runs through life-extension technology. On death, a standby team stabilizes the body, perfusion with cryoprotectant is performed at the Scottsdale facility, and the patient is cooled to liquid nitrogen temperature and stored in a dewar. Two options exist: whole-body preservation, and neuropreservation of the head alone, on the reasoning that any technology capable of revival could also supply a body. That reasoning leans on [[lab-grown-organs]] and on [[whole-brain-emulation]] as the alternative routes to a functioning person.Members sign a contract and fund it, most commonly by naming Alcor as beneficiary of a life insurance policy. The policy converts a large capital cost into a manageable premium and makes the arrangement cheap for people who are already insurable, one narrow instance of the [[access-and-inequality]] problem that runs through life-extension technology. On death, a standby team stabilizes the body, perfusion with cryoprotectant is performed at the Scottsdale facility, and the patient is cooled to liquid nitrogen temperature and stored in a dewar. Members choose between whole-body preservation and neuropreservation of the head alone. The second option rests on the reasoning that any technology capable of revival could also supply a body, which leans on [[lab-grown-organs]] and on [[whole-brain-emulation]] as the alternative routes to a functioning person. ## History## History Fred and Linda Chamberlain founded the organization in 1972 as the Alcor Society for Solid State Hypothermia, taking the name from a star in Ursa Major. It performed its first cryopreservation in 1976. The organization relocated from California to Scottsdale in 1994, partly for seismic and regulatory reasons.Fred and Linda Chamberlain founded the organization in 1972 as the Alcor Society for Solid State Hypothermia, taking the name from a star in Ursa Major. It performed its first cryopreservation in 1976. The organization relocated from California to Scottsdale in 1994, partly for seismic and regulatory reasons. Alcor also holds James Bedford, the first person ever cryopreserved, in 1967. His body was maintained privately by his family for decades and transferred to Alcor in 1991, where an inspection found the preservation had held despite decades of unstandardized storage.Alcor also holds James Bedford, who in 1967 became the first person ever cryopreserved. His family maintained his body privately for decades before transferring it to Alcor in 1991, where an inspection found the preservation had held despite decades of unstandardized storage. ```timeline```timeline[[ { "year": "1972", "title": "Founded", "text": "Fred and Linda Chamberlain incorporate the Alcor Society for Solid State Hypothermia in California." }, { "year": "1972", "title": "Founded", "text": "Fred and Linda Chamberlain incorporate the Alcor Society for Solid State Hypothermia in California." }, { "year": "1987–1990", "title": "The Dora Kent case", "text": "A coroner rules the death of a neuropreserved member a homicide; Alcor's facility is raided and staff are detained, but no charges result and the organization prevails in subsequent litigation." }, { "year": "1987-1990", "title": "The Dora Kent case", "text": "A coroner rules the death of a neuropreserved member a homicide; Alcor's facility is raided and staff are detained, but no charges result and the organization prevails in subsequent litigation." }, { "year": "1991", "title": "Bedford transferred", "text": "The body of James Bedford, cryopreserved in 1967, is moved to Alcor and inspected." }, { "year": "1991", "title": "Bedford transferred", "text": "The body of James Bedford, cryopreserved in 1967, is moved to Alcor and inspected." }, { "year": "1994", "title": "Move to Arizona", "text": "Operations relocate to Scottsdale, where the organization remains." }, { "year": "1994", "title": "Move to Arizona", "text": "Operations relocate to Scottsdale, where the organization remains." }, { "year": "c. 2001", "title": "Vitrification adopted", "text": "Alcor switches from freezing to vitrification using low-toxicity cryoprotectant solutions, displacing ice formation as the dominant damage mechanism in well-perfused tissue." }, { "year": "c. 2001", "title": "Vitrification adopted", "text": "Alcor switches from freezing to vitrification using low-toxicity cryoprotectant solutions, displacing ice formation as the dominant damage mechanism in well-perfused tissue." }, { "year": "2002", "title": "The Ted Williams case", "text": "The baseball player's cryopreservation becomes a public dispute among his heirs and generates lasting negative coverage." }, { "year": "2002", "title": "The Ted Williams case", "text": "The baseball player's cryopreservation becomes a public dispute among his heirs and generates lasting negative coverage." }, { "year": "2011–2020", "title": "The More years", "text": "The philosopher Max More serves as chief executive, professionalizing operations and raising the organization's public profile." } { "year": "2011-2020", "title": "The More years", "text": "The philosopher Max More serves as chief executive, professionalizing operations and raising the organization's public profile." }]]`````` ## Procedures## Procedures Alcor's operational sequence has three phases, and the first is where most of the variance lies.Alcor's operational sequence has three phases, and most of the variance arises in the first. **Standby and stabilization.** For a member dying in a hospital or hospice with warning, a team deploys in advance. After pronouncement, circulation is restored mechanically, cooling begins with ice, and drugs intended to limit reperfusion injury and clotting are administered. For an unwitnessed death, none of this happens, and warm ischemia proceeds for hours or days. The difference between the best and worst case is the single largest determinant of preservation quality, and Alcor's own case reports say so.**Standby and stabilization.** For a member dying in a hospital or hospice with warning, a team deploys in advance. After pronouncement, circulation is restored mechanically, cooling begins with ice, and drugs intended to limit reperfusion injury and clotting are administered. After an unwitnessed death none of this happens, and warm ischemia proceeds for hours or days. The gap between the best and worst case is the single largest determinant of preservation quality, as Alcor's own case reports say. **Cryoprotective perfusion.** Blood is replaced by a vitrification solution, ramped up in concentration over hours. Alcor uses solutions of the class developed at 21st Century Medicine, engineered to suppress ice at concentrations that are less toxic than earlier formulations. Perfusion quality is assessed by measures including cryoprotectant concentration in venous return and, for neuro cases, by observation of the brain surface.**Cryoprotective perfusion.** Blood is replaced by a vitrification solution whose concentration is ramped up over hours. Alcor uses solutions of the class developed at 21st Century Medicine, engineered to suppress ice at concentrations that are less toxic than earlier formulations. Perfusion quality is assessed by measures including cryoprotectant concentration in venous return and, for neuro cases, by observation of the brain surface. **Cooldown and storage.** Patients are cooled below the glass transition and then to −196 °C and stored inverted in dewars of liquid nitrogen, so that a failure of resupply exposes the feet before the head. Cooling below the glass transition produces thermal stress and fracturing, a documented and unresolved problem; intermediate-temperature storage has been discussed as a remedy and is more complex to maintain.**Cooldown and storage.** Patients are cooled below the glass transition and then to −196 °C, and are stored inverted in dewars of liquid nitrogen so that a failure of resupply exposes the feet before the head. Cooling below the glass transition produces thermal stress and fracturing, a documented and unresolved problem. Intermediate-temperature storage has been discussed as a remedy, though it is more complex to maintain. > [!caution] What Alcor does not claim> [!caution] What Alcor does not claim> The organization does not assert that its patients can be revived, that current methods preserve a person intact, or that any timeline exists. Its published position is that preservation is worth attempting because the alternative is certain, and because information may survive that present medicine cannot use. Cryobiology societies do not accept even this weaker claim as established.> The organization does not assert that its patients can be revived, that current methods preserve a person intact, or that any timeline exists. Its published position is that preservation is worth attempting because the alternative is certain, and because information may survive that present medicine cannot use. Cryobiology societies do not accept even this weaker claim as established. ## Controversies## Controversies **Dora Kent (1987).** Kent, the mother of an Alcor member, was neuropreserved shortly after her death at the Alcor facility. The Riverside County coroner concluded that barbiturates had been administered before death and issued a homicide finding; the facility was raided, staff were detained, and the organization fought the case for years. No charges were ultimately brought, and courts found substantially in Alcor's favour. The episode established, in practice, that the organization would litigate.**Dora Kent (1987).** Kent, the mother of an Alcor member, was neuropreserved shortly after her death at the Alcor facility. The Riverside County coroner concluded that barbiturates had been administered before death and issued a homicide finding. The facility was raided, staff were detained, and the organization fought the case for years. No charges were ultimately brought, and courts found substantially in Alcor's favour. The episode showed in practice that the organization would litigate. **Ted Williams (2002).** The cryopreservation of the baseball player, contested between his children, generated intense press coverage and a subsequent book by a former Alcor employee alleging mishandling of remains. Alcor disputed the account. Whatever the merits, the case fixed a public image of the organization that it has not escaped.**Ted Williams (2002).** The cryopreservation of the baseball player, contested between his children, generated intense press coverage and a later book by a former Alcor employee alleging mishandling of remains. Alcor disputed the account. Whatever the merits, the case fixed a public image of the organization that it has not escaped. **Institutional longevity.** The most serious criticism is structural rather than scandalous. Patients must be maintained for an unknown period by an organization that receives no further revenue from them. Alcor's answer is the Patient Care Trust, a segregated fund invested to cover maintenance from returns, with the operating organization legally distinct from it. The 1979 collapse of the Cryonics Society of California, in which stored bodies were found thawed after the organization ran out of money, is the field's worked example of what the structure is meant to prevent. Whether any private institution can hold that arrangement for two centuries is untested and untestable in advance.**Institutional longevity.** The most serious criticism concerns structure rather than scandal. Patients must be maintained for an unknown period by an organization that receives no further revenue from them. Alcor's answer is the Patient Care Trust, a segregated fund invested to cover maintenance from its returns and legally distinct from the operating organization. The 1979 collapse of the Cryonics Society of California, in which stored bodies were found thawed after the organization ran out of money, is the field's worked example of what the structure is meant to prevent. Whether any private institution can hold that arrangement for two centuries is untested and cannot be tested in advance. ## Membership and finances## Membership and finances Alcor has over a thousand members and roughly 250 patients in storage as of the mid-2020s, with growth that has been slow and approximately linear for decades. Minimum funding is $200,000 for whole-body and $80,000 for neuropreservation, with a portion allocated to the Patient Care Trust and the remainder to the cost of the procedure and standby.As of the mid-2020s Alcor has over a thousand members and roughly 250 patients in storage, and its growth has been slow and approximately linear for decades. Minimum funding is $200,000 for whole-body and $80,000 for neuropreservation. A portion goes to the Patient Care Trust and the remainder covers the procedure and standby. The membership is not representative. It skews technical, male, American, and drawn disproportionately from the [[transhumanism|transhumanist]] and software communities — the same population that produced [[extropianism]], with which Alcor's leadership has overlapped. Notable patients include the futurist [[fm-2030]] and the cryptographer Hal Finney. [[max-more]], who wrote the extropian principles, led the organization from 2011 to 2020.The membership is not representative. It skews technical, male and American, and is drawn disproportionately from the [[transhumanism|transhumanist]] and software communities, the same population that produced [[extropianism]], with which Alcor's leadership has overlapped. Notable patients include the futurist [[fm-2030]] and the cryptographer Hal Finney. [[max-more]], who wrote the extropian principles, led the organization from 2011 to 2020. ## Reception## Reception The Society for Cryobiology has distanced itself from cryonics for decades and at one point barred practitioners from membership. Its objection is not that low-temperature storage fails to arrest decay, which is uncontroversial physics, but that the ischemic and toxic injury sustained before and during preservation is unquantified, that no mammal has been revived from cryogenic temperature, and that describing the practice as medicine misleads the public.The Society for Cryobiology has distanced itself from cryonics for decades and at one point barred practitioners from membership. Its objection is not that low-temperature storage fails to arrest decay, which is uncontroversial physics. It objects that the ischemic and toxic injury sustained before and during preservation is unquantified, that no mammal has been revived from cryogenic temperature, and that describing the practice as medicine misleads the public. Supporters make a narrower argument. The relevant threshold is information-theoretic death, formalized by Ralph Merkle: whether the structures encoding memory and personality remain inferable, not whether tissue remains alive.[^merkle1994] The routes from there — cell-by-cell repair by hypothetical [[medical-nanorobots]], or scanning the [[brain-preservation|preserved brain]] and running it as an emulation on the [[substrate-independence]] premise — and the objections to each are set out under [[cryonics]]. Alcor's own literature endorses neither route and no timeline; critics respond that an unfalsifiable bet with an unbounded payoff is a poor guide to action, and that the resemblance to Pascal's wager is not accidental.Supporters make a narrower argument. The relevant threshold, in their view, is information-theoretic death as formalized by Ralph Merkle: whether the structures encoding memory and personality remain inferable, rather than whether tissue remains alive.[^merkle1994] Two routes lead on from there, cell-by-cell repair by hypothetical [[medical-nanorobots]], or scanning the [[brain-preservation|preserved brain]] and running it as an emulation on the [[substrate-independence]] premise; [[cryonics]] sets out both and the objections to each. Alcor's own literature endorses neither route and no timeline. Critics respond that an unfalsifiable bet with an unbounded payoff is a poor guide to action, and that the resemblance to Pascal's wager is not accidental. ## Outlook## Outlook The developments that would most change Alcor's position are happening outside it. Vitrification and rewarming of whole mammalian organs, driven by the [[organ-shortage]] and organ-banking field rather than by cryonics, has produced a vitrified rabbit kidney that supported an animal after transplantation[^fahy2009] and, more recently, rat kidneys rewarmed by inductive heating of infused magnetic nanoparticles and transplanted with restored function.[^han2023] Scaling that to larger organs would supply the first direct evidence that a large vitrified mammalian structure can be recovered. Separately, progress in [[connectomics]] toward reconstructing circuitry from preserved tissue bears on whether a preserved brain contains what the practice assumes it contains.The developments that would most change Alcor's position are happening outside it. Work on vitrifying and rewarming whole mammalian organs, driven by the [[organ-shortage]] and organ-banking field rather than by cryonics, has produced a vitrified rabbit kidney that supported an animal after transplantation.[^fahy2009] More recently it has produced rat kidneys rewarmed by inductive heating of infused magnetic nanoparticles and transplanted with restored function.[^han2023] Scaling that to larger organs would supply the first direct evidence that a large vitrified mammalian structure can be recovered. Separately, progress in [[connectomics]] toward reconstructing circuitry from preserved tissue bears on whether a preserved brain contains what the practice assumes it contains. Neither line of work will answer the question Alcor exists to answer, which is not technical. The organization is a wager that an institution can outlast the problem it was created to survive, and the only test of that is time.Neither line of work will answer the question Alcor exists to answer, because that question is not a technical one. The organization is a wager that an institution can outlast the problem it was created to survive, and only time can test that. ## See also## See also removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
99 lines are the same in both revisions, and 38 of them are not shown. Neither revision here is necessarily the current article — read Alcor Life Extension Foundation for the text this wiki stands behind today.